TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
PE Ratio: Premium Valuation
Above historical average, strong compound growth.
Left:
||||
Price-to-earnings ratio
Latest
56.38
↑ 32% above average
Average (9y)
42.72
Historical baseline
Range
High:73.69
Low:13.17
CAGR
+17.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 56.38 | +3.1% |
| 2024 | 54.66 | +30.8% |
| 2023 | 41.78 | -31.3% |
| 2022 | 60.79 | +76.7% |
| 2021 | 34.40 | +5.7% |
| 2020 | 32.56 | -55.8% |
| 2019 | 73.69 | +133.2% |
| 2018 | 31.60 | +12.3% |
| 2017 | 28.14 | +113.7% |
| 2016 | 13.17 | - |